SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-005307
Filing Date
2019-04-01
Accepted
2019-03-29 18:22:41
Documents
58
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2018_hoththerapeutics.htm 10-K 1067331
2 CERTIFICATION f10k2018ex31-1_hoththerap.htm EX-31.1 16332
3 CERTIFICATION f10k2018ex31-2_hoththerap.htm EX-31.2 16024
4 CERTIFICATION f10k2018ex32-1_hoththerap.htm EX-32.1 6792
5 GRAPHIC img_001.jpg GRAPHIC 88054
6 GRAPHIC img_002.jpg GRAPHIC 71532
7 GRAPHIC img_003.jpg GRAPHIC 66921
8 GRAPHIC img_004.jpg GRAPHIC 77391
9 GRAPHIC img_005.jpg GRAPHIC 28332
10 GRAPHIC img_006.jpg GRAPHIC 87310
  Complete submission text file 0001213900-19-005307.txt   3878448

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE hoth-20181231.xml EX-101.INS 360357
12 XBRL SCHEMA FILE hoth-20181231.xsd EX-101.SCH 36101
13 XBRL CALCULATION FILE hoth-20181231_cal.xml EX-101.CAL 41847
14 XBRL DEFINITION FILE hoth-20181231_def.xml EX-101.DEF 138920
15 XBRL LABEL FILE hoth-20181231_lab.xml EX-101.LAB 267327
16 XBRL PRESENTATION FILE hoth-20181231_pre.xml EX-101.PRE 210092
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38803 | Film No.: 19718172
SIC: 2834 Pharmaceutical Preparations